Tags

Type your tag names separated by a space and hit enter

Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation.

Abstract

This study assessed the effect of a 3-month course of pegylated interferon-alpha-2a (Peg-IFN-alpha-2a) in 3 liver transplant patients with chronic active hepatitis E. A virological response was sustained for 6 and 5 months in 2 patients after Peg-IFN-alpha-2a therapy was completed. A relapse was observed in the third patient.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    Department of Nephrology, Dialysis and Organ Transplantation, Centre Hospitalier Universitaire, Toulouse, France. kamar.n@chu-toulouse.fr

    , , , , , , , , , ,

    Source

    MeSH

    Adult
    Antiviral Agents
    Hepatitis E
    Hepatitis, Chronic
    Humans
    Interferon alpha-2
    Interferon-alpha
    Liver Transplantation
    Male
    Middle Aged
    Polyethylene Glycols
    Recombinant Proteins
    Secondary Prevention

    Pub Type(s)

    Case Reports
    Journal Article

    Language

    eng

    PubMed ID

    20113176

    Citation

    Kamar, Nassim, et al. "Pegylated Interferon-alpha for Treating Chronic Hepatitis E Virus Infection After Liver Transplantation." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, vol. 50, no. 5, 2010, pp. e30-3.
    Kamar N, Rostaing L, Abravanel F, et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis. 2010;50(5):e30-3.
    Kamar, N., Rostaing, L., Abravanel, F., Garrouste, C., Esposito, L., Cardeau-Desangles, I., ... Izopet, J. (2010). Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 50(5), pp. e30-3. doi:10.1086/650488.
    Kamar N, et al. Pegylated Interferon-alpha for Treating Chronic Hepatitis E Virus Infection After Liver Transplantation. Clin Infect Dis. 2010 Mar 1;50(5):e30-3. PubMed PMID: 20113176.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. AU - Kamar,Nassim, AU - Rostaing,Lionel, AU - Abravanel,Florence, AU - Garrouste,Cyril, AU - Esposito,Laure, AU - Cardeau-Desangles,Isabelle, AU - Mansuy,Jean Michel, AU - Selves,Janick, AU - Peron,Jean Marie, AU - Otal,Philippe, AU - Muscari,Fabrice, AU - Izopet,Jacques, PY - 2010/2/2/entrez PY - 2010/2/2/pubmed PY - 2010/4/16/medline SP - e30 EP - 3 JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America JO - Clin. Infect. Dis. VL - 50 IS - 5 N2 - This study assessed the effect of a 3-month course of pegylated interferon-alpha-2a (Peg-IFN-alpha-2a) in 3 liver transplant patients with chronic active hepatitis E. A virological response was sustained for 6 and 5 months in 2 patients after Peg-IFN-alpha-2a therapy was completed. A relapse was observed in the third patient. SN - 1537-6591 UR - https://www.unboundmedicine.com/medline/citation/20113176/full_citation L2 - https://academic.oup.com/cid/article-lookup/doi/10.1086/650488 DB - PRIME DP - Unbound Medicine ER -